Literature DB >> 19622088

The natural history and epidemiology of insect venom allergy: clinical implications.

M B Bilò1, F Bonifazi.   

Abstract

Hymenoptera stings can cause severe systemic allergic reactions and occasionally fatal anaphylaxis, which contribute significantly to morbidity and deterioration in health-related quality of life. The latest epidemiological data confirm the importance of insect sting allergy as a cause of anaphylaxis. Despite the high prevalence of asymptomatic sensitization, the prevalence of sting-induced systemic reactions (SRs) is low. However, to date, no parameter has been identified that can predict who will have a future reaction and whether it will be a large local reaction or anaphylactic. The combination of several concomitant factors, which include environmental, genetics and individual factors, may account for the occurrence of a system reaction in individual patients. Several not completely known factors may be associated with the severity of systemic re-stings. As about 50% of subjects with fatal sting reactions had no documented history of a previous SR, greater insight of the natural history and risk factors is required, especially in asymptomatic sensitized subjects. For patients with SRs, prevention of future severe allergic reactions starts with referral to an emergency department, correct administration of epinephrine by medical staff, referral to an allergist and coaching for the self-administration of epinephrine. However, most insect sting victims failed to seek medical advice and hospital attendance does not always correlate with the severity of the allergic reaction. Moreover, only about one-third of patients received a prescription for self-injectable epinephrine and were officially referred to an allergist after being discharged, causing the non- or delayed prescription of specific immunotherapy. Significantly, this means that at least half of the sting fatalities in patients with a positive history could have been avoided through the timely administration of specific immunotherapy. These findings indicate the urgent need to educate the general population and doctors on the management of venom-allergic patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622088     DOI: 10.1111/j.1365-2222.2009.03324.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  27 in total

Review 1.  Developments in the field of allergy in 2009 through the eyes of Clinical and Experimental Allergy.

Authors:  H W Chu; C M Lloyd; W Karmaus; P Maestrelli; P Mason; G Salcedo; J Thaikoottathil; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-11       Impact factor: 5.018

2.  The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis.

Authors:  A Heaps; S Carter; C Selwood; M Moody; J Unsworth; S Deacock; N Sumar; A Bansal; G Hayman; T El-Shanawany; P Williams; E Kaminski; S Jolles
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

3.  Epidemiology and risk factors of self-reported systemic allergic reactions to a Hymenoptera venom in beekeepers worldwide: a protocol for a systematic review of observational studies.

Authors:  Tanja Carli; Igor Locatelli; Mitja Košnik; Andreja Kukec
Journal:  BMJ Open       Date:  2022-07-05       Impact factor: 3.006

4.  Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis.

Authors:  Sara Micaletto; Kurt Ruetzler; Martin Bruesch; Peter Schmid-Grendelmeier
Journal:  Allergy Asthma Clin Immunol       Date:  2022-06-02       Impact factor: 3.373

5.  Intracutaneous Skin Tests and Serum IgE Levels Cannot Predict the Grade of Anaphylaxis in Patients with Insect Venom Allergies.

Authors:  Moritz M Hollstein; Silke S Matzke; Lisa Lorbeer; Susann Forkel; Thomas Fuchs; Christiane Lex; Timo Buhl
Journal:  J Asthma Allergy       Date:  2022-07-07

6.  Anxiety and Atopic Disease: Comorbidity in a Youth Mental Health Setting.

Authors:  Emily M Becker-Haimes; Kathleen I Diaz; Bryan A Haimes; Jill Ehrenreich-May
Journal:  Child Psychiatry Hum Dev       Date:  2017-08

7.  World allergy organization guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  World Allergy Organ J       Date:  2011-02-23       Impact factor: 4.084

8.  Honeybee venom immunotherapy: a comparative study using purified and nonpurified aqueous extracts in patients with normal Basal serum tryptase concentrations.

Authors:  M Beatrice Bilò; Barbara Cinti; M Feliciana Brianzoni; M Chiara Braschi; Martina Bonifazi; Leonardo Antonicelli
Journal:  J Allergy (Cairo)       Date:  2012-01-12

Review 9.  Venom immunotherapy for preventing allergic reactions to insect stings.

Authors:  Robert J Boyle; Mariam Elremeli; Juliet Hockenhull; Mary Gemma Cherry; Max K Bulsara; Michael Daniels; J N G Oude Elberink
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 10.  Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.

Authors:  Troy Wanandy; Emily Mulcahy; Wun Yee Lau; Simon G A Brown; Michael D Wiese
Journal:  Clin Rev Allergy Immunol       Date:  2021-06-01       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.